Division of Critical Care Medicine, Department of Pediatrics, Children's National Medical Center, Washington, DC.
Divisions of Critical Care Medicine and Nephrology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
Crit Care Med. 2023 Jun 1;51(6):765-774. doi: 10.1097/CCM.0000000000005836. Epub 2023 Mar 20.
Given the complex interrelatedness of fluid overload (FO), creatinine, acute kidney injury (AKI), and clinical outcomes, the association of AKI with poor outcomes in critically ill children may be underestimated due to definitions used. We aimed to disentangle these temporal relationships in a large cohort of children with acute respiratory distress syndrome (ARDS).
Retrospective cohort study.
Quaternary care PICU.
Seven hundred twenty intubated children with ARDS between 2011 and 2019.
None.
Daily fluid balance, urine output (UOP), and creatinine for days 1-7 of ARDS were retrospectively abstracted. A subset of patients had angiopoietin 2 (ANGPT2) quantified on days 1, 3, and 7. Patients were classified as AKI by Kidney Disease Improving Global Outcomes (KDIGO) stage 2/3 then grouped by timing of AKI onset (early if days 1-3 of ARDS, late if days 4-7 of ARDS, persistent if both) for comparison of PICU mortality and ventilator-free days (VFDs). A final category of "Cryptic AKI" was used to identify subjects who met KDIGO stage 2/3 criteria only when creatinine was adjusted for FO. Outcomes were compared between those who had Cryptic AKI identified by FO-adjusted creatinine versus those who had no AKI. Conventionally defined AKI occurred in 26% of patients (early 10%, late 3%, persistent 13%). AKI was associated with higher mortality and fewer VFDs, with no differences according to timing of onset. The Cryptic AKI group (6% of those labeled no AKI) had higher mortality and fewer VFDs than patients who did not meet AKI with FO-adjusted creatinine. FO, FO-adjusted creatinine, and ANGPT2 increased 1 day prior to meeting AKI criteria in the late AKI group.
AKI was associated with higher mortality and fewer VFDs in pediatric ARDS, irrespective of timing. FO-adjusted creatinine captures a group of patients with Cryptic AKI with outcomes approaching those who meet AKI by traditional criteria. Increases in FO, FO-adjusted creatinine, and ANGPT2 occur prior to meeting conventional AKI criteria.
由于液体超负荷(FO)、肌酐、急性肾损伤(AKI)和临床结局之间的复杂相互关系,由于使用的定义,危重病儿童中 AKI 与不良结局的关联可能被低估。我们旨在对急性呼吸窘迫综合征(ARDS)的大样本儿童中这些时间关系进行剖析。
回顾性队列研究。
四级儿童重症监护病房(PICU)。
2011 年至 2019 年间,721 名接受气管插管的 ARDS 患儿。
无。
回顾性提取 ARDS 第 1-7 天的每日液体平衡、尿量(UOP)和肌酐值。部分患者在第 1、3 和 7 天检测了血管生成素 2(ANGPT2)。根据 KDIGO 分期 2/3,患者被分为 AKI,然后根据 AKI 发病时间进行分组(ARDS 第 1-3 天为早期,第 4-7 天为晚期,持续时间均为晚期),以比较 PICU 死亡率和无呼吸机天数(VFDs)。最后,还使用了一个“隐匿性 AKI”类别来确定那些仅在肌酐校正 FO 后才符合 KDIGO 分期 2/3 标准的患者。将使用 FO 校正肌酐识别出隐匿性 AKI 的患者与无 AKI 的患者进行比较。在接受检测的患者中,有 26%的患者发生了 AKI(早期 10%,晚期 3%,持续性 13%)。AKI 与更高的死亡率和更少的 VFDs 相关,与发病时间无关。隐匿性 AKI 组(被标记为无 AKI 的患者中占 6%)的死亡率和更少的 VFDs 高于未使用 FO 校正肌酐识别 AKI 的患者。FO、FO 校正肌酐和 ANGPT2 在晚期 AKI 组中,在符合 AKI 标准前一天增加。
在儿科 ARDS 中,AKI 与更高的死亡率和更少的 VFDs 相关,与发病时间无关。FO 校正肌酐可捕获一组隐匿性 AKI 患者,其结局接近传统标准下 AKI 患者。FO、FO 校正肌酐和 ANGPT2 的增加发生在符合传统 AKI 标准之前。